Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The phase II study demonstrated that once-weekly subcutaneous dosing of CT-388 can lead to substantial placebo-adjusted weight loss at 48 weeks, with participants continuing to lose weight without reaching a plateau
Public Health
Compounding pharmacies can offer much more accessible alternatives to brand-name medications that are customized to the medical needs of the patient
I knew I didnt have much life left if I stayed on this path
Chat with a Mochi Medical provider
Medical oversight isn't optional when you're injecting medication that affects insulin regulation, how fast food moves through your stomach, and appetite signaling
US$ 26.12
US$ 26.38
US$ 27.08
US$ 20.45
US$ 23.65
